Patent · US Active

SPARC and methods of use thereof

US8420603B2 · kind B2 · utility

8Cited by
8References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 14, 2006
Grant dateApr 16, 2013
Priority date
Expiry dateJun 10, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/25
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods for predicting or determining the response of a mammalian tumor to a chemotherapeutic agent and for treating a mammalian tumor comprising detecting and quantifying the SPARC protein or RNA in a sample isolated from the mammal. The invention further provides kit for predicting the response of a mammalian tumor to a chemotherapeutic agent, comprising a means for the isolation of protein or RNA from the tumor, a SPARC protein or RNA detection and quantification means, control RNAs, and rules for predicting the response of the tumor based on the level of SPARC protein or RNA in tumor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.